Anastrozole and Tamoxifen Interaction

Avoid
Researched 95% confidence

Anastrozole and Tamoxifen have a potentially harmful interaction with 95% confidence. The ATAC trial and subsequent pharmacokinetic studies demonstrated that anastrozole significantly reduces plasma concentrations of endoxifen, tamoxifen's primary active metabolite, thereby reducing its effectiveness. This combination should be avoided. If aromatase inhibition is needed alongside a SERM, consider alternative combinations. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Tamoxifen

Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment

Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.

Half-life: ~5-7 days Typical dose: 20-40mg oral daily pct
cyp3a4estrogen receptor anticoagulantcarcinogenic riskhepatotoxicpct agent
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Anastrozole, Tamoxifen). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the pct-agent safety flag (Anastrozole, Tamoxifen). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Anastrozole, Tamoxifen). Monitor accordingly.

Frequently Asked Questions

Can I take Anastrozole with Tamoxifen?

Combining Anastrozole with Tamoxifen is not recommended. The ATAC trial and subsequent pharmacokinetic studies demonstrated that anastrozole significantly reduces plasma concentrations of endoxifen, tamoxifen's primary active metabolite, thereby reducing its effectiveness. This combination should be avoided. If aromatase inhibition is needed alongside a SERM, consider alternative combinations.

Is Anastrozole and Tamoxifen safe together?

This combination carries significant risk. The ATAC trial and subsequent pharmacokinetic studies demonstrated that anastrozole significantly reduces plasma concentrations of endoxifen, tamoxifen's primary active metabolite, thereby reducing its effectiveness. This combination should be avoided. If aromatase inhibition is needed alongside a SERM, consider alternative combinations. Consult a healthcare professional before combining.

What are the interactions between Anastrozole and Tamoxifen?

The ATAC trial and subsequent pharmacokinetic studies demonstrated that anastrozole significantly reduces plasma concentrations of endoxifen, tamoxifen's primary active metabolite, thereby reducing its effectiveness. This combination should be avoided. If aromatase inhibition is needed alongside a SERM, consider alternative combinations. This assessment has 95% confidence and is based on documented research data.

How should I time Anastrozole and Tamoxifen?

Anastrozole has a half-life of ~40-50 hours and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anastrozole vs Tamoxifen

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.